Target intelligence / Profile preview

Parkinsonism associated deglycase (DJ-1) (PARK7)

Target
PARK7
Molecular classification
Enzyme (Deglycase, putative glyoxalase, esterase/protease activity), Chaperone (redox-sensitive chaperone), Peptidase C56 family, Stress response protein
01

Overview

Parkinsonism associated deglycase (DJ-1, encoded by the PARK7 gene) is a highly conserved, multifunctional protein of the peptidase C56 family, primarily recognized for its roles in cellular defense against oxidative stress, DNA repair, and maintenance of protein and metabolite integrity[1][2][4]. DJ-1 forms a homodimer and exerts chaperone and redox sensor functions, inhibiting the aggregation of disease-associated proteins (such as α-synuclein) and protecting cells from oxidative and glycation-induced damage[1][4]. Mutation or loss of DJ-1 function is causally linked to autosomal recessive early-onset Parkinson's disease, while altered DJ-1 activity or expression is also implicated in a range of cancers. DJ-1’s diverse biochemical activities, including esterase, protease (under specific conditions), glyoxalase, and putative deglycase activities, underscore its reputation as a cellular "Swiss army knife"[1][4]. DJ-1 is considered an emerging therapeutic target for both neurodegeneration and cancer, though clinical drugs specifically targeting it remain in early phases of research.

Other names
DJ-1DJ1Protein DJ-1Parkinson disease protein 7GATD2Maillard deglycaseOncogene DJ1Protein/nucleic acid deglycase DJ-1HEL-S-67pEpididymis secretory sperm binding protein Li 67pParkinson disease (autosomal recessive, early onset) 7
02

Mechanism of action

Antioxidant: protecting cells from oxidative damage; Modulation of protein glycation and glyoxalase activity; Regulation of transcription (as coactivator for androgen receptor and other factors); Repair of glycated DNA/nucleotide adducts.

03

Biological functions

Protection against oxidative stressDNA repair (double-strand break repair via non-homologous end joining and homologous recombination)Protein and metabolite damage prevention (anti-glycation, anti-oxidation)Regulation of androgen receptor-dependent transcriptionEpigenetic regulationProtein quality control
04

Disease associations

Neurodegenerative disease (notably Parkinson's disease, especially early-onset, autosomal recessive type)Cancer (oncogene activity and involvement in cancer-related pathways)Other oxidative stress-related pathology
05

Safety considerations

Targeting DJ-1 may disrupt key neuroprotective and antioxidative functions, potentially exacerbating neurodegenerationOncogenic risk: DJ-1 is implicated as an oncogene, so modulation could affect tumorigenic potential in some cancers
06

Interacting drugs

Pyrroloquinoline quinone (PQQ) (shown to reduce DJ-1 self-oxidation)

1 more in the full profile.

07

Biomarkers

DJ-1 level in cerebrospinal fluid (biomarker for Parkinson's disease and other neurodegenerative disorders)DJ-1 oxidative modification status (potential biomarker for oxidative stress and disease state)

Beyond the preview

Go deeper on Parkinsonism associated deglycase (DJ-1) (PARK7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parkinsonism associated deglycase (DJ-1) (PARK7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call